Hancock Richard B 4
4 · Avid Bioservices, Inc. · Filed Jun 8, 2023
Insider Transaction Report
Form 4
Hancock Richard B
Director
Transactions
- Sale
Common Stock, $0.001 par value
2023-06-06$16.37/sh−4,988$81,646→ 39,134 total - Exercise/Conversion
Common Stock, $0.001 par value
2023-06-06$4.53/sh+12$54→ 39,146 total - Sale
Common Stock, $0.001 par value
2023-06-06$16.00/sh−12$192→ 39,134 total - Exercise/Conversion
Stock Option (right to buy)
2023-06-06−12→ 178,254 totalExercise: $4.53Exp: 2026-05-07→ Common Stock (12 underlying)
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2022.
- [F2]Represents a weighted average sales price per share. These shares were sold at prices ranging from $16.00 to $16.61. The Reporting Person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Stock option granted to the reporting person on May 7, 2019 vested annually over a four (4) year period and was fully-vested as of May 7, 2023.